Search

everythinglearnresearchcommunity

for

Search:↓

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document is a detailed medical reference on skin and genetic disorders.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Pimecrolimus cream is not effective for treating alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

New treatments for lupus show promise, but more research is needed, especially for children.